Focus Areas
- “Female Partner Thrives in Male-Dominated Life Sciences Legal Arena, Helps Build Women’s Network,” Of Counsel. September 2020.
- “The COVID-19 Virus Presents Contracting Opportunities and Challenges to Life Science and Biotechnology Companies,” Thompson Hine COVID-19 Update, March 2020
- “IPO Benefits and Challenges for Early-Stage Biotech Cos.,” Law360, December 2019
- “Diversity in the Life Sciences Industry: More Progress Needed,” AW360, November 2019
- “Benefits and Challenges of an Early Stage Biotech Company Going Public,” Thompson Hine Business Law Update, Summer 2019
- “Spin-Offs: Key Considerations,” Thompson Hine Business Law Update, Winter 2018
- Interviewed, “WIB Profile: Mergers, Funding, & Financing Continue to Surge In Biotech,” ClinicalLeader.com, July 2, 2015
- Interviewed, “NY women take on the biotech sector,” Crain’s New York Business, Source Lunch, May 23, 2014
- Recommended by LMG Life Sciences, Finance & Transactional, 2013-2016, 2024
- Named one of The Deal’s Top Women in Dealmaking, M&A and Private Equity, 2023
- Named a Notable Women in Law by Crain’s New York Business, 2020
- Graduate, Women in Bio’s First Boardroom Ready Program, George Washington University’s Executive Education School
- BTI Client Service All-Star
Professional Associations
- Board Member; Member, Nomination & Corporate Governance Committee; Chair, Compensation Committee – Conduit Pharmaceuticals, 2022-present
- Member, National Board of Directors – Women in Bio; founder of New York Chapter
- Member, Board of Directors – Red Door Community, New York City
- Founder and Co-Leader – BioDirector, New York Chapter
- Member, Life Sciences Council – Springboard Enterprises
- Member, Executive Committee, Life Sciences Sector – The Licensing Executive Society (USA and Canada)
- Board Chair; Member, Nominating Committee – CNS Pharmaceuticals, Inc. (Nasdaq: CNSP), 2022-present
- Board Member; Member, Audit Committee – Avenue Therapeutics, Inc. (Nasdaq: ATXI), 2022-present
- Board Member; Chair, Nomination & Corporate Governance Committee; Member, Compensation Committee – Abeona Therapeutics (Nasdaq: ABEO), 2021-present
- Board Member; Member, Audit Committee; Chair, Compensation Committee – Board of Directors, Entera Bio Ltd. (Nasdaq: ENTX), 2018-2021
- Member – CHIEF, New York City 2022-2023
- Board Member – Amydis, Inc., 2019-2022
- Board Member; Member, Audit Committee; Chair, Compensation Committee – Entera Bio Ltd., 2018-2021
- Board Member – Sandstone Diagnostics, Inc., 2018-2021
Education
- George Washington University Law Center, 1986
- Barnard College, B.A., 1983, cum laude
Bar Admissions
- New York
Languages
- Hebrew
- 03.06.24 – Essential Legal Must-Knows for Thriving in the Life Sciences Sector – Part 2
An Ohio Life Sciences Event Presented by Thompson Hine
- Thompson Hine Recognized by LMG Life Sciences 2024, September 9, 2024
- Vaxart’s $40 Million Common Stock Offering,
Lawyer Monthly
, August 27, 2024 - Thompson Hine’s Faith Charles Named a Top Dealmaker by The Deal,
Thompson Hine LLP
, March 30, 2023 - Female Partner Thrives in Male-Dominated Life Sciences Legal Arena, Helps Build Women’s Network,
Of Counsel
, September 10, 2020 - The COVID-19 Virus Presents Contracting Opportunities and Challenges to Life Science and Biotechnology Companies,
COVID-19 Update
, March 13, 2020 - 2020 Notable Women in Law, Crain’s New York Business – Faith Charles,
–Crain’s New York Business
, December 17, 2019 - Business Law Update – Summer 2019,
Thompson Hine Newsletter
, August 14, 2019